Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: Gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer

Journal of Translational Medicine

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ukNBig
via IFTTT